This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (82)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Psychiatry  • Immunologic Disorders  • Alert me on articles by topic

Association With Cerebral Inflammation

Klaus Fassbender, MD; Roland Schmidt, PhD; Reinald Mößner, MD; Udo Kischka, MD; Josy Kühnen, MD; Andreas Schwartz, MD; Michael Hennerici, MD

Arch Neurol. 1998;55:66-72.

Objective  To investigate the association between affective and neuroendocrine abnormalities, commonly observed in multiple sclerosis, with inflammatory disease activity.

Design  Cross-sectional design. Twenty-three patients with definite relapsing-remitting multiple sclerosis and age- and sex-matched control subjects were investigated. Depression and anxiety were assessed using structured interviews, self-report measures, and Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised criteria. Neurologic impairment was assessed by the Kurtzke Expanded Disability Status Scale and function of hypothalamic-adrenal-pituitary axis was analyzed using a corticotropin-releasing hormone stimulation test after dexamethasone suppression. Inflammatory disease activity was evaluated first by routine and experimental laboratory tests, and second by magnetic resonance assessment of gadolinium uptake of multiple sclerotic plaques.

Setting  University hospital, a major provider of acute neurologic care.

Results  Compared with controls, patients with multiple sclerosis had higher scores on depression and anxiety scales and exhibited a failure of suppression of cortisol release after dexamethasone pretreatment. Both affective symptoms and neuroendocrine abnormalities were correlated with cerebrospinal fluid white blood cell counts and presence of gadolinium-enhancing lesions on magnetic resonance images; however, no association with the degree of neurologic impairment was observed.

Conclusion  Affective and neuroendocrine disorders were related to inflammatory disease activity but not to degree of disability, supporting the hypothesis that these symptoms are causally associated with brain injury.

From the Departments of Neurology (Drs Fassbender, Mößner, Kischka, Kühnen, Schwartz, and Hennerici) and Clinical Chemistry (Dr Schmidt), University of Heidelberg, Klinikum Mannheim, Mannheim, Germany.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Influence of Positive Experiences on Depression and Quality of Life in Persons With Multiple Sclerosis
Phillips and Stuifbergen
J Holist Nurs 2008;26:41-48.
ABSTRACT  

Review: Brain immune communication psychoneuroimmunology of multiple sclerosis
Kern and Ziemssen
Mult Scler 2008;14:6-21.
ABSTRACT  

Relationship between stress and relapse in multiple sclerosis: part II. Direct and indirect relationships
Brown et al.
Mult Scler 2006;12:465-475.
ABSTRACT  

The neuropsychiatry of multiple sclerosis
Jefferies
Adv. Psychiatr. Treat. 2006;12:214-220.
ABSTRACT | FULL TEXT  

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Heesen et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:34-39.
ABSTRACT | FULL TEXT  

A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables
Brown et al.
Mult Scler 2005;11:477-484.
ABSTRACT  

The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group
Mult Scler 2005;11:328-337.
ABSTRACT  

Depression and fatigue in relapsing-remitting MS: the role of symptomatic variability
Randolph and Arnett
Mult Scler 2005;11:186-190.
ABSTRACT  

Sensitivity to Glucocorticoids Is Decreased in Relapsing Remitting Multiple Sclerosis
van Winsen et al.
J. Clin. Endocrinol. Metab. 2005;90:734-740.
ABSTRACT | FULL TEXT  

Structural brain abnormalities in multiple sclerosis patients with major depression
Feinstein et al.
Neurology 2004;62:586-590.
ABSTRACT | FULL TEXT  

Effects of Treatment for Depression on Fatigue in Multiple Sclerosis
Mohr et al.
Psychosom. Med. 2003;65:542-547.
ABSTRACT | FULL TEXT  

Tryptophan as a Link between Psychopathology and Somatic States
Russo et al.
Psychosom. Med. 2003;65:665-671.
ABSTRACT | FULL TEXT  

Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis
Di Legge et al.
Mult Scler 2003;9:302-306.
ABSTRACT  

Self-Reported Depressive Symptoms and Stress Levels in Healthy Young Men: Associations With the Cortisol Response to Awakening
Pruessner et al.
Psychosom. Med. 2003;65:92-99.
ABSTRACT | FULL TEXT  

Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis
Erkut et al.
Mult Scler 2002;8:229-236.
ABSTRACT  

The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope
Lynch et al.
Mult Scler 2001;7:411-416.
ABSTRACT  

Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis
Mohr et al.
Arch Neurol 2001;58:1081-1086.
ABSTRACT | FULL TEXT  

Combined Treatment with Corticosteroids and Moclobemide Favors Normalization of Hypothalamo-Pituitary-Adrenal Axis Dysregulation in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double Blind Trial
Bergh et al.
J. Clin. Endocrinol. Metab. 2001;86:1610-1615.
ABSTRACT | FULL TEXT  

Lesion pattern in patients with multiple sclerosis and depression
Berg et al.
Mult Scler 2000;6:156-162.
ABSTRACT  

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS
Bergh et al.
Neurology 1999;53:772-772.
ABSTRACT | FULL TEXT  

The relationship of MS to physical trauma and psychological stress: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Goodin et al.
Neurology 1999;52:1737-1737.
FULL TEXT